ChemoCentryx, Inc.
Method of treating liver fibrosis

Last updated:

Abstract:

A method of treating liver fibrosis with CCR2 antagonists is provided. The liver fibrosis may be associated with non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), emerging cirrhosis, non-cirrhotic hepatic fibrosis, type 2 diabetes mellitus (T2DM) or metabolic syndrome (MS).

Status:
Grant
Type:

Utility

Filling date:

2 Jun 2017

Issue date:

16 Jun 2020